Enseval Putera Megatrading (IDX:EPMT) - Share price, News & Analysis

EPMT fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	4/6

EPMT Stock Overview

PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products in Indonesia.

Rewards

Trading at 18.7% below our estimate of its fair value

Earnings have grown 9.8% per year over the past 5 years

Risk Analysis

Dividend of 6.99% is not well covered by earnings

Enseval Putera Megatrading Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Enseval Putera Megatrading
Historical stock prices
Current Share Price	Rp2,860.00
52 Week High	Rp2,990.00
52 Week Low	Rp2,200.00
Beta	-0.19
1 Month Change	4.38%
3 Month Change	4.00%
1 Year Change	25.99%
3 Year Change	19.17%
5 Year Change	-1.38%
Change since IPO	1,711.32%

Shareholder Returns

	EPMT	ID Healthcare	ID Market
7D	0%	-2.8%	-4.5%
1Y	26.0%	11.0%	15.7%

Return vs Industry: EPMT exceeded the ID Healthcare industry which returned 11% over the past year.

Return vs Market: EPMT exceeded the ID Market which returned 15.7% over the past year.

Price Volatility

Is EPMT's price volatile compared to industry and market?
EPMT volatility
EPMT Average Weekly Movement	1.8%
Healthcare Industry Average Movement	5.0%
Market Average Movement	6.1%
10% most volatile stocks in ID Market	12.1%
10% least volatile stocks in ID Market	3.0%

Stable Share Price: EPMT is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: EPMT's weekly volatility (2%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1973	5,125	Jos Atmadjaja	https://www.enseval.com

PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products in Indonesia. The company operates through three segments: Pharmaceutical, Consumer Products, and Others. It also trades in medical and laboratory equipment and supplies; operates health care clinics; and offers dental and other equipment, as well as calibration services.

Enseval Putera Megatrading Fundamentals Summary

How do Enseval Putera Megatrading's earnings and revenue compare to its market cap?
EPMT fundamental statistics
Market Cap	Rp7.75t
Earnings (TTM)	Rp879.55b
Revenue (TTM)	Rp26.70t

8.8x

P/E Ratio

0.3x

P/S Ratio

Is EPMT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
EPMT income statement (TTM)
Revenue	Rp26.70t
Cost of Revenue	Rp23.87t
Gross Profit	Rp2.83t
Other Expenses	Rp1.95t
Earnings	Rp879.55b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	324.72
Gross Margin	10.59%
Net Profit Margin	3.29%
Debt/Equity Ratio	2.1%

How did EPMT perform over the long term?

See historical performance and comparison

Dividends

7.0%

Current Dividend Yield

62%

Payout Ratio

Valuation

Is Enseval Putera Megatrading undervalued compared to its fair value and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

18.7%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: EPMT (IDR2860) is trading below our estimate of fair value (IDR3516.06)

Significantly Below Fair Value: EPMT is trading below fair value, but not by a significant amount.

Price To Earnings Ratio

PE vs Industry: EPMT is good value based on its PE Ratio (8.8x) compared to the ID Healthcare industry average (20x).

PE vs Market: EPMT is good value based on its PE Ratio (8.8x) compared to the ID market (19.2x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EPMT's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: EPMT is good value based on its PB Ratio (1.1x) compared to the ID Healthcare industry average (2x).

Future Growth

How is Enseval Putera Megatrading forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

17.0%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Enseval Putera Megatrading has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Enseval Putera Megatrading performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

9.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EPMT has high quality earnings.

Growing Profit Margin: EPMT's current net profit margins (3.3%) are higher than last year (3.2%).

Past Earnings Growth Analysis

Earnings Trend: EPMT's earnings have grown by 9.8% per year over the past 5 years.

Accelerating Growth: EPMT's earnings growth over the past year (19.4%) exceeds its 5-year average (9.8% per year).

Earnings vs Industry: EPMT earnings growth over the past year (19.4%) underperformed the Healthcare industry 121.6%.

Return on Equity

High ROE: EPMT's Return on Equity (12.4%) is considered low.

Financial Health

How is Enseval Putera Megatrading's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: EPMT's short term assets (IDR9,127.0B) exceed its short term liabilities (IDR3,516.9B).

Long Term Liabilities: EPMT's short term assets (IDR9,127.0B) exceed its long term liabilities (IDR116.4B).

Debt to Equity History and Analysis

Debt Level: EPMT has more cash than its total debt.

Reducing Debt: EPMT's debt to equity ratio has increased from 1.3% to 2.1% over the past 5 years.

Debt Coverage: EPMT's debt is well covered by operating cash flow (300.1%).

Interest Coverage: EPMT earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Dividend

What is Enseval Putera Megatrading current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

6.99%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: EPMT's dividend (6.99%) is higher than the bottom 25% of dividend payers in the ID market (1.14%).

High Dividend: EPMT's dividend (6.99%) is in the top 25% of dividend payers in the ID market (4.21%)

Stability and Growth of Payments

Stable Dividend: EPMT's dividend payments have been volatile in the past 10 years.

Growing Dividend: EPMT's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (61.6%), EPMT's dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (162.2%), EPMT's dividend payments are not well covered by cash flows.

Next Steps

Explore strong dividend paying companies in the Healthcare industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

4.5yrs

Average board tenure

CEO

Jos Atmadjaja (51 yo)

Tenure

Mr. Jos Iwan Atmadjaja serves as President Director at PT Enseval Putera Megatrading Tbk since May 2021. He serves as Head of Distribution & Logistic and Head of Health Services at PT Enseval Putera Megatr...

Board Members

Experienced Board: EPMT's board of directors are considered experienced (4.5 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/12 00:00
End of Day Share Price	2022/05/12 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31